Top Health Tech Companies in Melbourne (49)
Umps is a Victorian health-tech company redefining the personal alarm industry to help older adults and NDIS participants stay safe, independent and healthy at home for longer. Our flagship product, the Umps Link Home Alarm, is the culmination of six years of dedicated research and development, designed in collaboration with some of the largest aged care providers in Victoria and...
Intelerad is a leader enterprise workflow and medical image archiving solutions for all types of healthcare organizations. Renowned for their innovative features and functionality, Intelerad solutions, such as InteleViewer™ and InteleOne® XE, increase productivity and streamline workflow by overcoming technical barriers in distributed and complex environments. Highly scalable, flexible and robust, Intelerad’s solutions offer high performance and industry leading customer...
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems. At LivaNova, we understand the importance of bringing both clinical and economic value to...
LivaNova's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results indicate revenue rose at a double‑digit pace in 2025 and into early 2026, with management increasing full‑year growth guidance. Filings attribute momentum to broad strength across Cardiopulmonary and Neuromodulation.
Strong Market Position & Advantage: Evidence points to leadership in implantable VNS and a top‑tier position in cardiopulmonary perfusion, supported by a large installed base and competitor retrenchment. Independent coverage and recognition of pivotal studies reinforce defensible share within chosen niches.
Product Line Growth: Commercial uptake of the Essenz Perfusion System and steady consumables demand are driving cardiopulmonary expansion. Approval of the aura6000 device for obstructive sleep apnea and a connected‑care VNS roadmap add incremental growth avenues.
Sagility is a U.S.-based, tech-enabled healthcare business process management company that supports payers, providers, and their partners to deliver best-in-class operations, enhance the member and provider experience, improve the quality of care and promote health equity all while delivering cost-effective healthcare financial and clinical outcomes. Sagility Technologies uses a holistic consulting approach to identify the root causes of healthcare payer and...
Sagility's Top Stability & Growth Strengths
Strong Revenue Growth: Recent quarters show accelerated top-line expansion with management increasing full-year growth guidance. Momentum reflects both organic gains and contributions from recent acquisitions.
Profitability: Operating metrics indicate healthy margins and rising earnings alongside revenue growth. Commentary highlights disciplined execution during peak demand periods while maintaining margin targets.
Innovation-Driven Growth: AI-led solutions, analytics, and automation are cited as material drivers of wins and efficiency across payer and provider workflows. New offerings and deployed AI use cases appear to be supporting scale and client expansion.
PKG Health believes every person with a neurological condition deserves to live their best life every day. We leverage the world’s largest body of clinical evidence in neurology, to create and deliver precision medicine by accelerating the research, approval and adoption of treatments. Its lead product, the Parkinson's KinetiGraph®(PKG® or Personal KinetiGraph® in the US), has been developed by neurologists...
Acrux is a specialty pharma company with a successful track record of developing and commercialising a pipeline of topically applied pharmaceutical products. Drawing on 25 years of experience, Acrux has successfully marketed through licensees a number of products worldwide with emphasis on the United States. Acrux is formulating and developing a range of topical generic products by leveraging its highly...
Seer is a medical technology company on a mission to give people more control of their most valuable assets—their health and their time—by reimagining how and where they undergo long-term clinical monitoring. Seer's products and services are focused on solving the problems related to the early and accurate diagnosis of epilepsy. Seer’s flagship suite of technologies, offered through a provider...
We’re Medmate. Nice to meet you. We take the inconvenience and awkwardness out of pharmacy visits. Book a consultation with a doctor or get a script all online. It's fast, easy and convenient. Medmate was developed by doctors and pharmacists and born out of a desire to take the burden out of pharmacy shopping and make life that little bit...
Doctify is a high-growth HealthTech company revolutionising the global healthcare market. Having expanded into 6 markets with an ambitious growth plan over the coming year. Doctify has developed a first-of-its-kind healthcare-specific patient feedback and review product allowing healthcare professionals to drive improvements in patient care on a daily basis. Our SaaS product allows healthcare providers to collect and digitize patient feedback and...
At See-Mode, our mission is to unlock the hidden insights in medical imaging with AI, and empower clinicians to improve patient outcomes. Our AI-enhanced ultrasound reporting software automatically reads and assesses ultrasound images, producing accurate clinical reports.
Integra LifeSciences, a world leader in medical technology with headquarters in Princeton, New Jersey, was founded in 1989 with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Since then, Integra has expanded its base regenerative technology product portfolio to include surgical instruments, neurosurgical products and advanced wound care products, through global acquisitions and development...
Lenexa Medical is an Australian-based MedTech company that has developed the LenexaCARE technology to empower clinicians to deliver targeted, long-term solutions for personalised pressure injury prevention and patient monitoring. Pressure injuries are mostly preventable, however affect millions of people globally each year whilst costing healthcare systems billions of dollars worldwide. In 2020, Australian public hospitals spent over $9 billion to...
Natural MedTech is manufacturing psychedelic medicines to unlock neurologic potential. We are building Australia’s leading pure-play psychedelic business, with differentiated IP, an experienced team, and a self-funding growth profile.
Teladoc Health is on a mission to empower all people everywhere to live healthier lives by transforming the healthcare experience. Recognized as the world leader in whole-person virtual care, Teladoc Health addresses the full spectrum of health and well-being — powered by human expertise, advanced technology and insights—to deliver improved clinical outcomes at scale. Serving more than 175 countries and...
Teladoc Health's Top Stability & Growth Strengths
Strong Market Position & Advantage: Scale across enterprise and direct‑to‑consumer channels (including 17.1 million visits in 2025) and a broad integrated‑care stack position the company as a top multi‑specialty virtual‑care operator. External signals such as BetterHelp’s category scale and a top‑tier satisfaction ranking support durable competitive standing.
Cost & Operational Efficiency: Operating performance shows improving efficiency with a materially narrower net loss and stable adjusted EBITDA despite revenue pressure. Margin expansion in Integrated Care indicates better unit economics at scale.
Market Expansion: International revenue grew while insurance acceptance for BetterHelp expanded and new channels were pursued, signaling ongoing market expansion. These moves diversify geography and payer mix beyond U.S. cash‑pay exposures.
Bupa's purpose is helping people live longer, healthier, happier lives and making a better world. We are an international healthcare company serving over 38 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers. We directly employ around 85,000 people, principally in the UK, Australia, Spain, Chile, Poland, New...
Bupa's Top Stability & Growth Strengths
Strong Revenue Growth: Group results show double‑digit revenue and underlying profit growth in 2024, with customers rising sharply. 2025 materials indicate continued revenue and profit increases alongside a larger customer base, with growth remaining solid even excluding first‑time consolidation effects.
Strong Market Position & Advantage: Independent market analysis places Bupa as the UK PMI leader within a concentrated 'big four', and official statistics show it as the largest fund in Australian private health insurance. Bupa Global is viewed as a tier‑one IPMI provider, and the insurer‑plus‑provider model strengthens competitive positioning across multiple regions.
Market Expansion: Company updates highlight ongoing expansion of clinics, dental centres, hospitals and digital health (Blua), with dozens of new sites opened in 2024 and further additions in 2025. Portfolio moves such as consolidating Niva Bupa in India and adding UK provision assets broaden reach into fast‑growing markets and channels.
Montu is the leading medical cannabis company committed to improve the lives of millions of patients.
Mesoblast (ASX:MSB; Nasdaq:MESO) is developing and commercializing allogeneic cellular medicines to treat serious and life-threatening inflammatory diseases with significant, unmet medical needs. The Company's Phase 3 off-the-shelf mesenchymal lineage cell product candidates are: • RYONCIL™ (remestemcel-L) for steroid-refractory acute graft versus host disease (acute GVHD) • Remestemcel-L for moderate to severe acute respiratory distress syndrome (ARDS) due to COVID-19 infection • REVASCOR® for advanced...
Nanochap is a fabless semiconductor company with its core R&D team based in Melbourne, Australia. We specialise in neural interface and biosensing SoCs. The company is committed to the R&D, design, packaging, testing, and commercialisation of ultra-high density neural interface chips, biosensing chips, and other medical device related chips.
Aravax is a clinical stage biotechnology company developing a novel peptide-based immunotherapy, PVX108, for the treatment of peanut allergy. Aravax is striving to improve the lives of patients living with peanut allergies by developing a therapy that precisely targets the underlying cause of disease, bringing benefits in safety and convenience.
Welcome to Cabrini Health Cabrini is owned and operated by the Missionary Sisters of the Sacred Heart of Jesus who came to Australia in 1948 to take over the management of a 45-bed community hospital named St Benedict’s. Cabrini now has more than 800 beds and a comprehensive range of health services. There are acute facilities at Malvern and Brighton. The...
